Literature DB >> 16055565

Differential requirements for survivin in hematopoietic cell development.

Sandeep Gurbuxani1, Yanfei Xu, Ganesan Keerthivasan, Amittha Wickrema, John D Crispino.   

Abstract

Although erythroid cells and megakaryocytes arise from a common progenitor, their terminal maturation follows very different paths; erythroid cells undergo cell-cycle exit and enucleation, whereas megakaryocytes continue to progress through the cell cycle but skip late stages of mitosis to become polyploid cells. In our efforts to identify genes that participate in this process, we discovered that survivin, a member of the inhibitor of apoptosis family that also has an essential role in cytokinesis, is differentially expressed during erythroid versus megakaryocyte development. Erythroid cells express survivin throughout their maturation, whereas megakaryocytes express approximately 4-fold lower levels of survivin mRNA and no detectable protein. To investigate the role of survivin in these lineages, we overexpressed or knocked down survivin from mouse bone marrow cells and then examined erythroid and megakaryocyte development. These studies revealed that overexpression of survivin antagonized megakaryocyte growth, maturation, and polyploidization but had no effect on erythroid development. This block in polyploidization was accompanied by increased expression of p21 and decreased expression of megakaryocyte genes such as von Willebrand factor and beta(1)-tubulin. In contrast, a reduction in survivin expression interfered with the formation of erythroid cells but not megakaryocytes. Last, consistent with the requirement for survivin in the survival of proliferating cells, survivin-deficient hematopoietic progenitors failed to give rise to either erythroid or megakaryocytic colonies. Together, these studies show that whereas survivin expression is essential for megakaryocyte and erythroid progenitors, its down-regulation is required for terminal differentiation of megakaryocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055565      PMCID: PMC1183538          DOI: 10.1073/pnas.0500303102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Roads to polyploidy: the megakaryocyte example.

Authors:  Katya Ravid; Jun Lu; Jeffrey M Zimmet; Matthew R Jones
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

2.  Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation.

Authors:  Urszula Wojda; Pierre Noel; Jeffery L Miller
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

3.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

4.  INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis.

Authors:  S P Wheatley; A Carvalho; P Vagnarelli; W C Earnshaw
Journal:  Curr Biol       Date:  2001-06-05       Impact factor: 10.834

5.  Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes.

Authors:  V Baccini; L Roy; N Vitrat; H Chagraoui; S Sabri; J P Le Couedic; N Debili; F Wendling; W Vainchenker
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

6.  Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.

Authors:  Andrew G Muntean; John D Crispino
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

7.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.

Authors:  S Fukuda; L M Pelus
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

8.  Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype.

Authors:  A G Uren; L Wong; M Pakusch; K J Fowler; F J Burrows; D L Vaux; K H Choo
Journal:  Curr Biol       Date:  2000-11-02       Impact factor: 10.834

9.  Pleiotropic cell-division defects and apoptosis induced by interference with survivin function.

Authors:  F Li; E J Ackermann; C F Bennett; A L Rothermel; J Plescia; S Tognin; A Villa; P C Marchisio; D C Altieri
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

10.  Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells.

Authors:  A Kawasaki; I Matsumura; S Ezoe; H Tanaka; Y Terada; M Tatsuka; T Machii; H Miyazaki; Y Furukawa; Y Kanakura
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

View more
  47 in total

1.  Survivin localization during endomitosis of high ploidy mouse megakaryocytes.

Authors:  Donald J McCrann; Katya Ravid
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

Review 2.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues.

Authors:  B Spaulding; D Pan; A Ghadersohi; G Nielsen; S Jensen; F Gellert; X Ling; M Zhang; A Black; F Li
Journal:  Histopathology       Date:  2006-12       Impact factor: 5.087

Review 4.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

5.  Acetylation of EKLF is essential for epigenetic modification and transcriptional activation of the beta-globin locus.

Authors:  Tanushri Sengupta; Ken Chen; Eric Milot; James J Bieker
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 6.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

7.  Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.

Authors:  Zhanxiang Wang; Louis M Pelus
Journal:  Cancer Ther       Date:  2008

8.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

9.  Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress.

Authors:  Chin-Yi Kan; Carlotta Petti; Lauryn Bracken; Michelle Maritz; Ning Xu; Rosemary O'Brien; Chen Yang; Tao Liu; Jun Yuan; Richard B Lock; Karen L MacKenzie
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

10.  Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets.

Authors:  Ilham Chelh; Bruno Meunier; Brigitte Picard; Mark James Reecy; Catherine Chevalier; Jean-François Hocquette; Isabelle Cassar-Malek
Journal:  BMC Genomics       Date:  2009-04-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.